European Journal of Hospital Pharmacy

Papers
(The TQCC of European Journal of Hospital Pharmacy is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 236
Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-1934
CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions30
Antifungal drug resistance: an update28
Automation of in-hospital pharmacy dispensing: a systematic review25
Severe and fatal medication errors in hospitals: findings from the Norwegian Incident Reporting System25
Prevalence of drug interactions in hospitalised elderly patients: a systematic review24
Results of EAHP’s 2019 Medicines Shortages Survey22
Implementation of a novel home delivery service during pandemic21
Effectiveness, safety and cost analysis of dalbavancin in clinical practice20
Observational study on off-label use of tocilizumab in patients with severe COVID-1917
Cost-effectiveness analysis of pembrolizumab plus standard chemotherapy versus chemotherapy alone for first-line treatment of metastatic non-squamous non–small-cell lung cancer in China17
Evaluation of the stability of vancomycin solutions at concentrations used in clinical services15
Toward a better understanding about real-world evidence14
Performance and risks of ChatGPT used in drug information: an exploratory real-world analysis12
Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study12
Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic12
Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-1912
Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital11
Epinephrine use in COVID-19: friend or foe?11
Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series11
A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report10
The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak10
Therapeutic efficacy of tacrolimus in vernal keratoconjunctivitis: a meta-analysis of randomised controlled trials10
Petechial skin rash associated with CoronaVac vaccination: first cutaneous side effect report before phase 3 results9
Assessment of the stability of citrate-buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial ch9
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part B: risk control9
Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy9
External contamination of antineoplastic drug vials: an occupational risk to consider8
Impact and acceptance of pharmacist-led interventions during HIV care in a third-level hospital in Spain using the Capacity-Motivation-Opportunity pharmaceutical care model: the IRAFE study8
Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients8
Predictive performance of reported vancomycin population pharmacokinetic model in patients with different renal function status, especially those with augmented renal clearance8
An update on extravasation: basic knowledge for clinical pharmacists7
Are we offering patients the right medicines information? A retrospective evaluation of readability and quality in online patient drug information7
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part A: risk assessment7
The incidence and risk of cutaneous toxicities associated with dabrafenib in melanoma patients: a systematic review and meta-analysis7
Automated unit dose dispensing systems producing individually packaged and labelled drugs for inpatients: a systematic review7
Dramatic improvement of bullous pemphigoid with omalizumab in an elderly patient7
COVID-19 vaccine triggered autoimmune hepatitis: case report7
Exploring the adverse effects of chemotherapeutic agents used in the treatment of cervical and ovarian cancer from the patients’ perspective: a content analysis of the online discussion forums6
Creating the position of surgical pharmacist in China6
Evaluation of inappropriate antibiotic prescribing and management through pharmacist-led antimicrobial stewardship programmes: a meta-analysis of evidence6
Widening the net: a literature review of antimicrobial agents with potential suitability for outpatient parenteral antimicrobial therapy services—the importance of storage and stability6
Incidence and associated risk factors of antituberculosis drug-induced hepatotoxicity among hospitalised patients in Wuhan, China6
Patient prioritisation for hospital pharmacy services: current approaches in the UK6
Impact of pharmacist interventions on drug-related problems in general surgery patients: a randomised controlled trial6
Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients6
Identification and safe storage of look-alike, sound-alike medicines in automated dispensing cabinets5
Systematic review of the stability of antimicrobial agents in elastomeric devices for outpatient parenteral antimicrobial therapy services based on NHS Yellow Cover Document standards5
Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series5
Red for danger in systematic reviews?5
Administration of benralizumab in a patient with severe asthma admitted to the intensive care unit with COVID-19 pneumonia: case report5
Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain5
Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-195
Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates5
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis5
Dabigatran trough concentrations in very elderly patients5
Omega-3 for the prevention of cardiovascular diseases: meta-analysis and trial-sequential analysis5
Detection of subclinical nephrotoxicity induced by aminoglycosides in critically ill elderly patients using trough levels and urinary neutrophil gelatinase-associated lipocalin5
Pegylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia: a literature review of pharmaceutical and clinical aspects5
What influences the implementation and sustainability of antibiotic stewardship programmes in hospitals? A qualitative study of antibiotic pharmacists’ perspectives across South West England5
Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists5
Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study4
Medication review versus usual care to improve drug therapies in hospitalised older patients admitted to internal medicine wards4
Use of simulation for education in hospital pharmaceutical technologies: a systematic review4
An investigation into prescribing errors made by independent pharmacist prescribers and medical prescribers at a large acute NHS hospital trust: a cross-sectional study4
Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity4
Budget impact analysis of bevacizumab biosimilars for cancer treatment in adult patients in Spain4
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care units4
Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?4
RETRACTED: Specific features of rational pharmacotherapy in elderly patients4
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results4
Impact of pharmacist-led interventions in improving adherence to glaucoma medications in the geriatric population4
Medication persistence on biological therapies prescribed for the treatment of chronic inflammatory arthropathies: a real-world data study4
Managing antibiotic shortages: lessons from EAHP and ECDC surveys4
Adverse drug reactions of statin therapy in China from 1989 to 2019: a national database analysis4
Availability of antidotes in Moroccan hospitals: a national survey4
Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients4
The importance of publishing research protocols for pharmacoeconomic studies4
Development and validation of a risk prediction model for linezolid-induced thrombocytopenia in elderly patients4
Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital3
Drug-related problems in hospitalised Parkinson’s disease patients in China3
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document3
Tobramycin and vestibulotoxicity: retrospective analysis of four cases3
Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome3
Improving the quality of publications in and advancing the paradigms of clinical and social pharmacy practice research: the Granada Statements3
Comparison of metaraminol versus no metaraminol on time to resolution of shock in critically ill patients3
Defining innovativeness of high-technology medical devices in an Italian region3
Development of a list with renally relevant drugs as a tool to increase medicines optimisation in patients with chronic kidney disease3
Permanent renal sequelae secondary to drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by quetiapine3
Tezacaftor-ivacaftor use in routine care of adults with cystic fibrosis: a medicine use evaluation3
Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance3
Role of the hospital pharmacist in an Italian antimicrobial stewardship programme3
Effect of a pharmacist-led educational intervention on clinical outcomes: a randomised controlled study in patients with hypertension, type 2 diabetes and hypercholesterolaemia3
Surgical pharmacy: the knowledge system of surgical pharmacists3
Pharmacy preparations and compounding3
COvid MEdicaTion (COMET) study: protocol for a cohort study3
Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies3
Fighting on two fronts: drug–drug interactions in people living with HIV infected with SARS-CoV-23
Levofloxacin induced bullous fixed drug eruption: a rare case report3
The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic3
Factors influencing the implementation of clinical pharmacy services on paediatric patient care in hospital settings3
A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib3
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs3
Therapeutic drug monitoring of voriconazole: validation of a high performance liquid chromatography method and comparison with an ARK immunoassay3
Criteria for the selection of paediatric patients susceptible to reconciliation error2
Short-term study on in-use stability of opened bevacizumab biosimilar PF-06439535 vials2
Successful treatment of interstitial pneumonitis with anakinra in a patient with adult-onset Still’s disease2
Is there a multinational consensus of tobramycin prescribing and monitoring for cystic fibrosis? Survey of current therapeutic drug monitoring practices in USA/Canada, UK/Ireland, and Australia/New Ze2
Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine2
Analysis of standard concentrations of continuous infusions in nine Spanish neonatal intensive care units2
Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome2
Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients withEnterococcus faeciumbacteraemia: a retrospective cohort study2
Vancomycin in neonatal sepsis: predictive performance of a Chinese neonatal population pharmacokinetic model and clinical efficacy evaluation2
Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction2
Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey2
A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic2
European health data space proposal launched2
Analysis of production time and capacity for manual and robotic compounding scenarios for parenteral hazardous drugs2
Automatic dispensing cabinets and governance of controlled drugs: an exploratory study in an intensive care unit2
Antimicrobial resistance in Nigeria: challenges and charting the way forward2
Lopinavir/ritonavir, a new galenic oral formulation from commercial solid form, fine-tuned by nuclear magnetic resonance spectroscopy2
The impact of paediatric dose range checking software2
Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation2
Design and validation of a predictive equation to estimate unbound valproic acid concentration2
Observational study of drug-related problems and clinical pharmacists’ interventions in a French paediatric hospital2
Pharmacotherapeutic management of Parkinson’s disease inpatients: how about asking hospital pharmacists?2
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence2
Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA2
Economic evaluation of subcutaneous versus intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy: a real-life study2
Clinical practice and teaching of pharmaceutical care procedures for obstetric diseases2
Comparison of area under the curve for vancomycin from one- and two-compartment models using sparse data2
Successful treatment of Verona integron-encoded metallo-β-lactamase-producingKlebsiella pneumoniaeinfection using the combination of ceftazidime/avibactam and aztreonam2
Improving shared decision-making in pharmacist-led haematology clinics: a ‘Plan Do Study Act’ approach2
Is it safe to use remdesivir in combination with a combined p-glycoprotein and CYP3A4 inhibitor?2
Potential costs and consequences associated with medication error at hospital discharge: an expert judgement study2
An unusual case of piperacillin-tazobactam-induced fever, eosinophilia, thrombocytopenia and liver damage2
Tocilizumab in COVID-19 management: addressing time of starting treatment2
Benefit versus toxicity risk of digoxin in patients with COVID-192
Development and validation of a ready-to-use score to prioritise medication reconciliation at patient admission in an orthopaedic and trauma department2
In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion2
Reducing the risk of non-sterility of aseptic handling in hospital pharmacies, part C: applying risk assessment and risk control in practice2
Is it safe to use visible blue light-emitting diode phototherapy for neonatal jaundice in infants who are also treated with amiodarone?2
Off-label use of inhaled bronchodilators in hospitalised patients in Spain: a multicentre observational study2
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in a paediatric patient taking zonisamide2
Rational selection of inhalation devices in the treatment of chronic obstructive pulmonary disease by means of the System of Objectified Judgement Analysis (SOJA)2
Long-term stability of ready-to-use norepinephrine solution at 0.2 and 0.5 mg/mL2
Clinical frailty and polypharmacy in older emergency critical care patients: a single-centre retrospective case series2
How can we optimise the pharmaceutical analysis of radiopharmaceutical pediatric prescriptions?2
Rosuvastatin-induced rhabdomyolysis: case report and call for proactive multifactorial risk assessment and preventive management of statin therapy in high-risk patients2
Therapeutic drug monitoring of linezolid: HPLC-based assays for routine quantification of linezolid in human serum and cerebrospinal fluid2
Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study2
Analysis of the third WHO Global Safety Challenge ‘Medication Without Harm’ patient-facing materials: exploratory descriptive study2
Daptomycin in combination with rosuvastatin induced blood creatine phosphokinase elevation2
Comparison of three automated compounding devices for parenteral nutrition according to four key technical tests2
Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection2
The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients2
Risk of acute kidney injury by initiation of non-steroidal anti-inflammatory drugs in hospitalised patients treated with diuretics and renin–angiotensin–aldosterone system inhibitors2
Is sitagliptin effective for the treatment of COVID-19?2
Polymyxin B-related neurotoxicity: a brief case report2
Drug-related bradycardia precipitating hospital admission in older adults: an ongoing problem2
Goal attainment scaling to facilitate person-centred, medicines-related consultations2
Haemolytic anaemia induced by flutamide: a case report2
Stability and compatibility of admixtures containing bupivacaine hydrochloride and ketorolac tromethamine for parenteral use2
Formulation and stability of an extemporaneously compounded propafenone hydrochloride oral suspension for children with arrhythmia2
Antimicrobial resistance: a major priority for global focus2
Effectiveness and safety of sofosbuvir/velpatasvir ± ribavirin vs glecaprevir/pibrentasvir in genotype 3 hepatitis C virus infected patients2
Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy2
Haemorrhagic complications in patients with renal insufficiency during treatment or prophylaxis with dalteparin2
Evaluation of the impact of the addition of a heart failure prescribing pharmacist to consultant-led heart failure ward round at a tertiary hospital2
0.025240898132324